Frølunde, Anne Sofie
Thyssen, Jacob Pontoppidan
Deleuran, Mette
Vestergaard, Christian http://orcid.org/0000-0002-5857-0626
Article History
Accepted: 7 July 2021
First Online: 28 July 2021
Declarations
:
: A.S. Frølunde performed the literature search, drafted and finished the manuscript. J.P. Thyssen critically revised the work and provided design of figures. M. Deleuran critically revised the manuscript. C. Vestergaard performed the literature search, drafted and revised the manuscript.
: No sources of funding were used to conduct this study or prepare this manuscript.
: AS Frølunde has no conflicts of interest that are directly relevant to the content of this article. Dr. Thyssen has been an advisor, speaker or investigator for AbbVie, Pfizer, LEO Pharma, Regeneron, Sanofi-Genzyme and Eli Lilly and Co. Dr. Deleuran has been an advisor, speaker or investigator for AbbVie, Pfizer, LEO Pharma, Regeneron, Sanofi-Genzyme, Eli Lilly, and Incyte. Dr. Vestergaard has received honoraria for lecturing and participation on advisory boards from Leo Pharma, Novartis, MEDA, AbbVie, Pfizer, Pierre Fabre and Sanofi-Genzyme and has received grants from Pfizer, LEO Pharma and Sanofi-Genzyme.
: Not applicable.
: Not applicable
: Not applicable
: Not applicable